Global law firm White & Case LLP has advised Hello Heart, the only digital therapeutic that focuses exclusively on heart health, on its US$70 million Series D financing. The financing, which was led by growth equity firm Stripes, will help support Hello Heart's significant growth in customer demand.
The company's flagship solution is an FDA-cleared blood pressure monitor coupled with an app. The app empowers people to track their blood pressure, pulse, medications, weight and activity using AI-based technology. The app provides real-time alerts to extremely high readings and encourages users to reach out to their physicians and healthcare professionals to catch risk in time.
The White & Case team was led by partner Tali Sealman, and included associate Gabrielle Hodgson (both in Silicon Valley).
This round of financing follows Hello Heart's Series C financing in May 2021 and its Series B financing in July 2019, for both of which the same White & Case team also advised Hello Heart.
For more information please speak to your local media contact.